Want to join the conversation?
$OREX's wholly owned subsidiary Orexigen Therapeutics Ireland, Ltd. entered into a distributorship agreement for Contrave with Korea-based company Kwang Dong Pharmaceutical Company, Ltd. Kwang Dong expects to begin marketing Contrave in 2H16. For the nine months ended Sept. 30, 2015, $OREX recognized revenues under this agreement of $61,000.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!